Neuome Peptides Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $4.33M

  • Investors
  • 3

Neuome Peptides General Information

Description

Developer of a peptide-based applied technology designed for clinical diagnostics. The company specializes in using a peptide-based approach to disrupt and democratize the diagnostics industry with affordable devices that provide lab-quality results in a fraction of the time and at a fraction of the cost, enabling clinicians to make rapid, informed decisions for improved patient care and outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 71 Ayer Rajah Crescent
  • Number 03-04/05
  • Singapore, 139951
  • Singapore
+65 6776
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 71 Ayer Rajah Crescent
  • Number 03-04/05
  • Singapore, 139951
  • Singapore
+65 6776

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuome Peptides Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 09-May-2022 $4.33M Completed Startup
To view Neuome Peptides’s complete valuation and funding history, request access »

Neuome Peptides Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Neuome Peptides’s complete cap table history, request access »

Neuome Peptides Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
EIGHT NDX VENTURES PTE. LTD. Corporation Minority
Mercatus Capital Family Office Minority
New Keynes Investments Venture Capital Minority
To view Neuome Peptides’s complete investors history, request access »

Neuome Peptides FAQs

  • When was Neuome Peptides founded?

    Neuome Peptides was founded in 2020.

  • Where is Neuome Peptides headquartered?

    Neuome Peptides is headquartered in Singapore, Singapore.

  • What industry is Neuome Peptides in?

    Neuome Peptides’s primary industry is Drug Discovery.

  • Is Neuome Peptides a private or public company?

    Neuome Peptides is a Private company.

  • What is the current valuation of Neuome Peptides?

    The current valuation of Neuome Peptides is .

  • What is Neuome Peptides’s current revenue?

    The current revenue for Neuome Peptides is .

  • How much funding has Neuome Peptides raised over time?

    Neuome Peptides has raised $4.33M.

  • Who are Neuome Peptides’s investors?

    EIGHT NDX VENTURES PTE. LTD., Mercatus Capital, and New Keynes Investments have invested in Neuome Peptides.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process